Lasa Supergeneri

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
7.01
-0.09 (-1.27%)
BSENSE

Mar 23

BSE+NSE Vol: 86.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.01",
    "chg": -0.09,
    "chgp": "-1.27%",
    "dir": -1,
    "prev_price": "7.10",
    "mcapval": "36.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE670X01014",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "86.32 k",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Ltd Falls to 52-Week Low of Rs 7 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amid-continued-downtrend-3907860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3907860.png",
        "date": "2026-03-23 12:40:45",
        "description": "For the second consecutive session, Lasa Supergenerics Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 7 on 23 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains stark against its sector and benchmark indices."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3902826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_mojoScore_3902826.png",
        "date": "2026-03-20 10:10:18",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amid-continued-downtrend-3900286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3900286.png",
        "date": "2026-03-19 10:19:38",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.05 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing financial and market pressures."
      },
      {
        "title": "Lasa Supergenerics Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-falls-to-52-week-low-amid-continued-downtrend-3894434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3894434.png",
        "date": "2026-03-16 16:06:00",
        "description": "Lasa Supergenerics Ltd has touched a new 52-week low, closing just 0.42% above its lowest price of Rs 7.13, marking a significant decline amid persistent downward momentum in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3873097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_mojoScore_3873097.png",
        "date": "2026-03-05 10:10:37",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low at Rs.7.13",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-at-rs713-3869722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3869722.png",
        "date": "2026-03-04 12:11:37",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.7.13, marking a significant decline in its stock price amid ongoing market pressures and company-specific financial concerns."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3869720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3869720.png",
        "date": "2026-03-04 12:11:34",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.7.13 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific factors."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Falls to 52-Week Low of Rs.7.29",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-falls-to-52-week-low-of-rs729-3864898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LasaSupergeneri_priceRelatedfactors_3864898.png",
        "date": "2026-03-02 12:50:33",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.29 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3848435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_priceRelatedfactors_3848435.png",
        "date": "2026-02-20 11:11:34",
        "description": "Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.59 today, marking a significant decline amid a broader market recovery. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued performance metrics."
      }
    ],
    "total": 230,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Results For Quarter Ended 31St December 2025",
      "datetime": "13-Feb-2026",
      "details": "Results for quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing For Quarter Ended December 31 2025",
      "datetime": "13-Feb-2026",
      "details": "Integrated filing for quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended 31St December 2025",
      "datetime": "13-Feb-2026",
      "details": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Results For Quarter Ended 31St December 2025

13-Feb-2026 | Source : BSE

Results for quarter ended 31st December 2025

Integrated Filing For Quarter Ended December 31 2025

13-Feb-2026 | Source : BSE

Integrated filing for quarter ended December 31 2025

Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended 31St December 2025

13-Feb-2026 | Source : BSE

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available